Breaking News
Sort by:
Top Post
CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
GSK to Acquire Clinical-stage Biopharmaceutical Company Affinivax, Inc.
GSK plc (LSE/NYSE: GSK) today announced that it has entered into a definitive agreement to […]
GSK Announces Positive Phase III Efficacy and Safety Data for Daprodustat in Patients with Anaemia Due to Chronic Kidney Disease
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced positive results from the Phase III ASCEND (Anaemia Studies in […]
EU Commission Approves Benlysta for Lupus Nephritis
GlaxoSmithKline plc (GSK) today announced the European Commission has approved the expanded use of intravenous […]
FDA Grants Accelerated Approval for GSK’s JEMPERLI (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has […]
Lilly, Vir, GSK Announce Positive Topline Data from Phase 2 BLAZE-4 Trial
Eli Lilly and Company (NYSE: LLY), Vir Biotechnology, Inc. (NASDAQ: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today announced […]
- Toragen Announces Appointment of Chief Scientific Officer Read more
- First Citizens Bank Provides $31.2 Million for Acquisition of Cancer Treatment Center in Columbia, South Carolina Read more
- Roche Expands Collaboration with Janssen to Advance Personalised Healthcare Through Companion Diagnostics Read more
- ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Read more
- Superior HealthPlan and eFamilyCare Expand Partnership to Support Medicaid Members and Caregivers in Texas Read more